Skip to content

Polypeptide N-acetylgalactosaminyltransferase 11 (GALNT11)

Homo sapiens — UniProt Q8NCW6

Gene: GALNT11Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Polypeptide N-acetylgalactosaminyltransferase 11 (GALNT11) is a protein from Homo sapiens identified by UniProt accession Q8NCW6, 608 residues long. MolForge cross-references it against 0 known binders and 62 disease associations.

  • UniProt accession: Q8NCW6; gene symbol GALNT11.
  • Organism: Homo sapiens.
  • Length: 608 amino acids.
  • Top disease associations (Open Targets): Kleefstra syndrome 2, adolescent idiopathic scoliosis and glioblastoma multiforme.
  • 3D structure: AlphaFold model available.

Target properties

Protein namePolypeptide N-acetylgalactosaminyltransferase 11
UniProt accessionQ8NCW6
GeneGALNT11
OrganismHomo sapiens
Length608 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (62)

Diseases linked to this target (Open Targets).

  • Kleefstra syndrome 2 · score 0.34
  • adolescent idiopathic scoliosis · score 0.24
  • glioblastoma multiforme · score 0.13
  • familial idiopathic steroid-resistant nephrotic syndrome · score 0.06
  • nephrotic syndrome · score 0.05
  • focal segmental glomerulosclerosis · score 0.05
  • congenital nephrotic syndrome, Finnish type · score 0.04
  • xanthinuria type II · score 0.04
  • pentosuria · score 0.04
  • hyperprolinemia type 1 · score 0.04

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q8NCW6-F1alphafoldPREDICTED85.13—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q8NCW6.

Amino-acid sequence (608 residues)

MGSVTVRYFC YGCLFTSATW TVLLFVYFNF SEVTQPLKNV PVKGSGPHGP SPKKFYPRFT RGPSRVLEPQ FKANKIDDVI DSRVEDPEEG HLKFSSELGM IFNERDQELR DLGYQKHAFN MLISDRLGYH RDVPDTRNAA CKEKFYPPDL PAASVVICFY NEAFSALLRT VHSVIDRTPA HLLHEIILVD DDSDFDDLKG ELDEYVQKYL PGKIKVIRNT KREGLIRGRM IGAAHATGEV LVFLDSHCEV NVMWLQPLLA AIREDRHTVV CPVIDIISAD TLAYSSSPVV RGGFNWGLHF KWDLVPLSEL GRAEGATAPI KSPTMAGGLF AMNRQYFHEL GQYDSGMDIW GGENLEISFR IWMCGGKLFI IPCSRVGHIF RKRRPYGSPE GQDTMTHNSL RLAHVWLDEY KEQYFSLRPD LKTKSYGNIS ERVELRKKLG CKSFKWYLDN VYPEMQISGS HAKPQQPIFV NRGPKRPKVL QRGRLYHLQT NKCLVAQGRP SQKGGLVVLK ACDYSDPNQI WIYNEEHELV LNSLLCLDMS ETRSSDPPRL MKCHGSGGSQ QWTFGKNNRL YQVSVGQCLR AVDPLGQKGS VAMAICDGSS SQQWHLEG

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with GALNT11?

The strongest Open Targets associations for GALNT11 are Kleefstra syndrome 2, adolescent idiopathic scoliosis, glioblastoma multiforme, familial idiopathic steroid-resistant nephrotic syndrome and nephrotic syndrome.

How long is the GALNT11 protein?

The Homo sapiens GALNT11 protein (UniProt Q8NCW6) is 608 amino acids long.

Browse: Targets: G · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Polypeptide N-acetylgalactosaminyltransferase 11 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ8NCW6
GeneGALNT11
OrganismHomo sapiens
Length608
Binders0
Diseases62
View on UniProt